Stocks and Investing Stocks and Investing
Fri, May 20, 2022
Thu, May 19, 2022
Wed, May 18, 2022

Yasmeen Rahimi Maintained (ALT) at Buy with Decreased Target to $25 on, May 18th, 2022


Published on 2024-10-27 21:10:26 - WOPRAI, Yasmeen Rahimi
  Print publication without navigation


Yasmeen Rahimi of Piper Sandler, Maintained "Altimmune, Inc." (ALT) at Buy with Decreased Target from $34 to $25 on, May 18th, 2022.

Yasmeen, nor any peers, have made any analyst calls on ALT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30